EA200601390A1 - COMPOSITIONS OF MODAFINILLA - Google Patents
COMPOSITIONS OF MODAFINILLAInfo
- Publication number
- EA200601390A1 EA200601390A1 EA200601390A EA200601390A EA200601390A1 EA 200601390 A1 EA200601390 A1 EA 200601390A1 EA 200601390 A EA200601390 A EA 200601390A EA 200601390 A EA200601390 A EA 200601390A EA 200601390 A1 EA200601390 A1 EA 200601390A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- modafinilla
- compositions
- enantiomerically
- narcolepsy
- polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Получают и обсуждают полиморфы и сольваты рацемического, энантиомерно чистого и энантиомерно смешанного модафинила. Кроме того, указанные формы описаны как пригодные для лечения многих заболеваний, включающих в себя, но не ограничивающихся перечисленным, нарколепсию.The polymorphs and solvates of racemic, enantiomerically pure and enantiomerically mixed modafinil are prepared and discussed. In addition, these forms are described as suitable for the treatment of many diseases, including, but not limited to, narcolepsy.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54275204P | 2004-02-06 | 2004-02-06 | |
US56041104P | 2004-04-06 | 2004-04-06 | |
US57341204P | 2004-05-21 | 2004-05-21 | |
US57917604P | 2004-06-12 | 2004-06-12 | |
US58199204P | 2004-06-22 | 2004-06-22 | |
US58675204P | 2004-07-09 | 2004-07-09 | |
US58823604P | 2004-07-15 | 2004-07-15 | |
PCT/US2004/029013 WO2005023198A2 (en) | 2003-09-04 | 2004-09-04 | Modafinil compositions |
US63178604P | 2004-11-30 | 2004-11-30 | |
PCT/US2005/002782 WO2005077894A1 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200601390A1 true EA200601390A1 (en) | 2006-12-29 |
EA009949B1 EA009949B1 (en) | 2008-04-28 |
Family
ID=38456572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200601390A EA009949B1 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1718607A4 (en) |
JP (1) | JP4917441B2 (en) |
AU (1) | AU2005212229B2 (en) |
CA (1) | CA2556106A1 (en) |
EA (1) | EA009949B1 (en) |
IL (1) | IL176934A (en) |
WO (1) | WO2005077894A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4906233B2 (en) | 2002-03-01 | 2012-03-28 | ユニバーシティー オブ サウス フロリダ | Multi-component solid phase containing at least one active pharmaceutical ingredient |
AU2003243699B2 (en) | 2002-06-21 | 2009-01-15 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
FR2849029B1 (en) | 2002-12-20 | 2005-03-18 | Lafon Labor | PROCESS FOR THE PREPARATION AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL. |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
WO2005099822A2 (en) * | 2004-04-13 | 2005-10-27 | Cephalon, Inc. | Reduction of drug / drug interactions with modafinil |
EP1828098A1 (en) * | 2005-11-22 | 2007-09-05 | Teva Pharmaceutical Industries Ltd | Crystal forms of cinacalcet hci and processes for their preparation |
CN100343228C (en) * | 2006-02-17 | 2007-10-17 | 中国科学院上海有机化学研究所 | Selective prepn process of single antimer of 2-dibenzylsulfenyl-acetamide with higher antimer |
JP2009508880A (en) * | 2006-02-21 | 2009-03-05 | テバ ファーマシューティカル インダストリーズ リミティド | Novel crystal form of armodafinil and its preparation method |
EP2155664A2 (en) * | 2007-06-04 | 2010-02-24 | Generics Ýuk¨Limited | Novel process |
WO2009025791A2 (en) | 2007-08-16 | 2009-02-26 | Teva Pharmaceutical Industries Ltd. | Purification of armodafinil |
WO2009045488A2 (en) * | 2007-10-02 | 2009-04-09 | Teva Pharmaceutical Industries Ltd. | Novel crystalline forms of armodafinil and preparation thereof |
WO2009090663A1 (en) * | 2008-01-15 | 2009-07-23 | Lupin Limited | Novel crystalline polymorph of armodafinil and an improved process for preparation thereof |
KR102126389B1 (en) * | 2018-09-14 | 2020-06-25 | 셀라이온바이오메드 주식회사 | A composition for preventing or treating liver diseases comprising benzhydrylthio acetamide derivative as an active ingredient |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2593809B1 (en) * | 1986-01-31 | 1988-07-22 | Lafon Labor | BENZHYDRYLSULFINYLACETAMIDE, PROCESS FOR PREPARATION AND THERAPEUTIC USE |
FR2804322B1 (en) * | 2000-01-31 | 2002-04-19 | Lafon Labor | USE OF MODAFINIL FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR CORRECTING VIGILANCE DISORDERS ASSOCIATED WITH MYOPATHIES |
KR20060097771A (en) * | 2000-07-27 | 2006-09-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | Crystalline and pure modafinil, and process of preparing the same |
FR2849029B1 (en) * | 2002-12-20 | 2005-03-18 | Lafon Labor | PROCESS FOR THE PREPARATION AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL. |
-
2005
- 2005-02-01 EP EP05712282A patent/EP1718607A4/en not_active Ceased
- 2005-02-01 EA EA200601390A patent/EA009949B1/en not_active IP Right Cessation
- 2005-02-01 WO PCT/US2005/002782 patent/WO2005077894A1/en active Application Filing
- 2005-02-01 CA CA002556106A patent/CA2556106A1/en not_active Abandoned
- 2005-02-01 AU AU2005212229A patent/AU2005212229B2/en not_active Ceased
- 2005-02-01 JP JP2006552169A patent/JP4917441B2/en not_active Expired - Fee Related
-
2006
- 2006-07-18 IL IL176934A patent/IL176934A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4917441B2 (en) | 2012-04-18 |
AU2005212229B2 (en) | 2011-06-09 |
IL176934A0 (en) | 2006-12-10 |
EP1718607A1 (en) | 2006-11-08 |
WO2005077894A1 (en) | 2005-08-25 |
CA2556106A1 (en) | 2005-08-25 |
AU2005212229A1 (en) | 2005-08-25 |
EA009949B1 (en) | 2008-04-28 |
EP1718607A4 (en) | 2008-05-28 |
IL176934A (en) | 2013-06-27 |
JP2007522147A (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200601390A1 (en) | COMPOSITIONS OF MODAFINILLA | |
TW200719892A (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
EA200700225A1 (en) | TETRAPTIDE ANALOGUES | |
EA200700175A1 (en) | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY DISEASES | |
EA200800909A1 (en) | OBTAINING PREGABALIN AND RELATED COMPOUNDS | |
EA201101084A1 (en) | PHENOXYACIC ACIDS AS PPAR DELTA ACTIVATORS | |
EA200801560A1 (en) | BIFENYL CARBOKSAMIDES | |
MY163480A (en) | Sclerostin binding agents | |
ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EA200700489A1 (en) | NEW BENZO-CONDENSED HETEROARYL SULFAMIDE DERIVATIVES, USEFUL AS ANTI-CONVOLTIVE AGENT | |
EA200870019A1 (en) | LACTAMIC CONNECTIONS AND METHODS OF THEIR APPLICATION | |
TW200716584A (en) | Dihydrobenzofuran derivatives and uses thereof | |
EA201070422A1 (en) | OXADIAZOL DERIVATIVES | |
EA200801291A1 (en) | CARBONYLAMINOPYRROPYRAZOLES AS AN EFFICIENT KINAZ INHIBITORS | |
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
HK1085140A1 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
WO2005000860A3 (en) | Compositions and methods for treatment of disease with acetylated disaccharides | |
EA200870514A1 (en) | ACETYLENE HETEROARRYL COMPOUNDS | |
MXPA06000407A (en) | Cci-779 isomer c. | |
EA200600588A1 (en) | COMPOUNDS CONTAINING Haloalkyl As Inhibitors Of Cystine Proteases | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
TW200734306A (en) | Novel compounds, their preparation and use | |
TW200738649A (en) | Calcilytic compounds | |
DK1641803T3 (en) | Thienopyrimidine derivatives as potassium channel inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |